Additional investigations into mechanisms behind regorafenib resistance in HCC found that resistance is mediated via proteins controlling the cell cycle and proliferation—NF-κB, STAT3, Akt, cMyc [252,253,254,255]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.